Response to paper by Binkowska <i>et al</i>. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Douxfils, Jonathan; Foidart, Jean-Michel; Gaspard, Ulysse; Chatel, Guillaume; Taziaux, Mélanie; Jost, Maud; Gérard, Céline; Morimont, Laure

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Douxfils, Jonathan; Foidart, Jean-Michel; Gaspard, Ulysse; Chatel, Guillaume; Taziaux, Mélanie; Jost, Maud; Gérard, Céline; Morimont, Laure.

Afiliación

Douxfils J; Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.
Foidart JM; Department of Gynecology, University of Liège, Liège, Belgium.
Gaspard U; Department of Gynecology, University of Liège, Liège, Belgium.
Chatel G; Mithra Pharmaceuticals, Liège, Belgium.
Taziaux M; Mithra Pharmaceuticals, Liège, Belgium.
Jost M; Mithra Pharmaceuticals, Liège, Belgium.
Gérard C; Mithra Pharmaceuticals, Liège, Belgium.
Morimont L; Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.

Prz Menopauzalny ; 22(2): 117-119, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37674929

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Revista: Prz Menopauzalny Año: 2023 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google